Design principles for noninvasive, longitudinal and quantitative cell tracking with nanoparticle-based CT imaging.

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Medical Imaging

Background:

• Clinical trial inconsistencies hinder cell-based therapy progress.
• Understanding transplanted cell fate is crucial for therapy advancement.
• Current methods for tracking cells in vivo are limited.

Purpose of the Study:

• To develop and validate a noninvasive in vivo cell tracking technique.
• To utilize gold nanoparticles as contrast agents for computed tomography (CT) imaging.
• To assess the technique's efficacy in tracking therapeutic cells after intramuscular transplantation.

Main Methods:

• Development of a cell tracking method using gold nanoparticles for CT imaging.
• Longitudinal in vivo studies to monitor transplanted cells over extended periods.
• Quantification of detected cells and assessment of cell functionality in a disease model.

Main Results:

• Successful noninvasive tracking of transplanted cells over long durations.
• Detection limit as low as 500 cells.
• Demonstrated ability to quantify cell numbers and monitor cell functionality.
• Application in a mouse model for Duchenne muscular dystrophy.

Conclusions:

• The developed gold nanoparticle-based CT imaging technique enables sensitive and quantitative noninvasive cell tracking in vivo.
• This technology can elucidate transplanted cell fate, addressing a key challenge in cell therapy.
• The technique holds significant potential for pre-clinical and clinical cell therapy trials.